There is an enzyme in the brain that plays a key role in sensing and controlling levels of glucose in the blood. The underlying mechanism that it triggers appears to link to both type 1 and type 2 diabetes, according to US researchers, who suggest the discovery could lead to new treatments for diabetes.
A group of European health regulators have recommended the approval of a drug treatment that combines long-lasting insulin with a drug that promotes insulin secretion. Also in the news: A new study is examining whether a common gout medication can help prevent kidney disease in people with Type 1 diabetes.
There is no doubt that exercising with diabetes is about one million times more challenging than exercising without diabetes, particularly if you take insulin. Low blood sugars and high blood sugars are major party-poopers in the middle of a walk, yoga, spinning class, tai chi, or strength-training.
Writing in Nature Medicine, researchers from Stanford University School of Medicine, CA, describe how the new handheld microchip test shows not only high sensitivity and specificity for the diagnosis of type 1 diabetes, but also potential to discover previously unknown biomarkers of the disease.
For some people with diabetes, manipulating insulin to achieve weight loss has turned into a dangerous phenomenon nicknamed “diabulimia.” Diabulimia is a portmanteau of diabetes and bulimia and is believed in some estimates to affect approximately 30% of women with Type 1 diabetes.
Did you know that people with Type 1 diabetes also are at greater risk of having celiac disease? The odds of having celiac disease are 5 times to 7 times times greater for people with Type 1 diabetes than for the general population.
A meta-analysis of 3,619 deaths among individuals with diabetes and those who also had a history of foot ulcers reported a high risk of mortality from any cause in those patients who had diabetic foot ulcers; relative risk was 1.89.
his month, we attended the 74th annual Scientific Sessions of the American Diabetes Association, the largest diabetes conferences of the year. Lucky for us, it was held in our hometown of San Francisco. The conference featured updates on major progress with the artificial pancreas, a new and exciting (and a bit daunting) position statement for […]
The team from Columbia University Medical Center in New York City said their findings hold promise for the development of a new treatment for type 1 diabetes that does not involve stem cells.
In some estimates, it’s believed that as many as 2.6% of people with diabetes experience some form of allergic reaction to various forms of insulin. Such cases are uncommon, but they have been documented. Reactions range from frustrating to life-threatening.
Two famous studies showed that tight control of glucose did not cause a statistically significant reduction in heart attacks or early death. But roughly 20 years after the studies ended, tight control subjects are living longer and healthier than those who were in the comparison groups. What is going on?
Each year, more than 15,000 experts in the field of diabetes convene at the American Diabetes Association’s Scientific Sessions to hear the latest news in diabetes research, medical devices, and clinical practices. At Insulin Nation, we’ve summed up 7 additional big ideas at this year’s sessions.
The link between depression and mortality has often been studied in type 2 diabetes, but research of this in type 1 diabetes patients is rare, she noted.
An automated “bionic” pancreas that incorporates glucagon as well as insulin has shown improved blood glucose for five consecutive days in a study of patients with type 1 diabetes.
Combining two different medications could help patients with Type 1 diabetes at least partially regain the ability to produce their own insulin, a University of Florida study has shown.
According to experts, patients under the age of 19 should try to maintain an A1C blood sugar level that’s less than 7.5 percent. A1C is a test that measures the average blood sugar (glucose) levels over the span of several months, according to a news release.
In two small clinical studies presented at a meeting of the American Diabetes Association in San Francisco on Sunday, researchers said patients with Type 1 diabetes were able to better control their blood sugar when using an insulin-pump system controlled by an algorithm, or mathematical formula, which was embedded in a smartphone application, than when […]
Investigators at the University of Cincinnati (UC) have found a therapy that reverses new onset Type 1 diabetes in mouse models and may advance efforts in combating the disease among humans. The study, led by William Ridgway, MD, was presented Saturday, June 14, 2014, at the American Diabetes Association’s 74th Scientific Sessions in San Francisco.
In a recent scientific publication, JDRF-funded researchers used a radiotracer or marker and PET (Positron Emission Tomography) scanning as a non-invasive technique to follow changes in how many active beta cells a person has. Dr. Olle Korsgren and his colleagues at the University of Uppsala in Sweden used the technique in a clinical study of […]
What’s scary is that this ignorance is not limited to the general public; many medical professionals we’ve encountered lack even basic knowledge of the difference in these two diseases. If some doctors and nurses don’t have even a rudimentary understanding, how can we hope for ordinary people to understand?